Research graph
References from Incidence, timing and predictors of intracerebral haemorrhage after intravenous thrombolysis in patients with minor ischaemic stroke. Local targets link to admitted publications; unresolved targets remain external evidence.
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association
2026 · External reference
10.1161/strokeaha.120.031329
10.1161/strokeaha.120.031329 · External reference
10.1136/svn-2023-002673
10.1136/svn-2023-002673 · External reference
10.1212/cpj.0000000000000632
10.1212/cpj.0000000000000632 · External reference
10.1161/strokeaha.118.021398
10.1161/strokeaha.118.021398 · External reference
10.1161/circulationaha.119.040713
10.1161/circulationaha.119.040713 · External reference
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
10.1016/s1474-4422(24)00436-8 · 2025 · External reference
Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial
10.1001/jamanetworkopen.2023.25415 · 2023 · External reference
Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke: A Phase IIa Randomized Clinical Trial
10.1007/s12975-022-01012-9 · 2022 · External reference
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort
10.1161/jaha.124.036275 · 2024 · External reference
10.1093/eurheartj/ehaf702
10.1093/eurheartj/ehaf702 · External reference
Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort
10.1186/s12933-025-02721-9 · 2025 · External reference
Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis
10.1186/s12883-021-02222-8 · 2021 · External reference
Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke
10.1186/s12974-016-0680-x · 2016 · External reference
Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
10.3390/ijms22094405 · 2021 · External reference
10.1007/s00401-014-1381-0
10.1007/s00401-014-1381-0 · External reference
10.1007/s00401-014-1355-2
10.1007/s00401-014-1355-2 · External reference
10.1038/jcbfm.2015.45
10.1038/jcbfm.2015.45 · External reference
10.1161/strokeaha.113.002274
10.1161/strokeaha.113.002274 · External reference
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways
10.1016/j.vph.2014.11.007 · 2015 · External reference
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
10.1212/wnl.0000000000009756 · 2020 · External reference
Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis
10.1016/j.jstrokecerebrovasdis.2019.104363 · 2019 · External reference
10.1159/000321516
10.1159/000321516 · External reference
